Related Experiment Video

Updated: Jul 8, 2025

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
06:48

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells

Published on: June 16, 2022

2.0K

MicroRNA-204-5p Inhibits Hepatocellular Carcinoma by Targeting the Regulator of G Protein Signaling 20

Yanqing Su1,2, Yao Lu2,3, Honglin An2

  • 1Department of Pharmacy, Xiamen Children's Hospital, Xiamen, Fujian 361006, China.

ACS Pharmacology & Translational Science
|December 14, 2023
PubMed

Insights

Regulator of G protein signaling 20 (RGS20) promotes hepatocellular carcinoma (HCC) progression. MicroRNA-204-5p inhibits HCC by targeting and downregulating RGS20, suggesting therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The role of Regulator of G protein signaling 20 (RGS20) in hepatocellular carcinoma (HCC) is largely unknown.
  • MicroRNAs (miRNAs) are increasingly recognized for their roles in cancer development and progression.

Purpose of the Study:

  • To investigate the involvement of the miR-204-5p/RGS20 axis in HCC.
  • To determine if RGS20 is a direct target of miR-204-5p and to elucidate their functional relationship in HCC cells.

Main Methods:

  • Bioinformatic analysis using starBase, miRDB, TargetScan, and mirDIP databases to identify miRNAs targeting RGS20.
  • Dual-luciferase reporter assay and cDNA chip analysis to confirm direct targeting.
  • Cell viability, proliferation, apoptosis, cell cycle, and invasion/migration assays in HCC cell lines (PLC/PRF/5, Hep3B) with altered miR-204-5p and RGS20 expression.

Main Results:

  • miR-204-5p was identified as a direct regulator of RGS20, downregulating its expression in HCC.
  • High RGS20 expression correlated with poor prognosis in HCC patients.
  • Overexpression of miR-204-5p inhibited HCC cell proliferation, migration, and invasion, while promoting apoptosis. These effects were reversed by RGS20 overexpression.

Conclusions:

  • miR-204-5p acts as a tumor suppressor in HCC by targeting RGS20 and inhibiting its oncogenic functions.
  • RGS20 is a potential therapeutic target for HCC treatment.
  • miR-204-5p holds promise as a potential agent for miRNA-based gene therapy in HCC.

More Related Videos

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

17.6K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.6K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K